579
Views
4
CrossRef citations to date
0
Altmetric
Letter to the Editor

Challenges in COVID-19: is pulmonary thromboembolism related to overall severity?

, , ORCID Icon, , , , , , , , & show all
Pages 585-589 | Received 04 May 2020, Accepted 11 May 2020, Published online: 01 Jun 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Andrea Borghesi, Salvatore Golemi, Nicola Carapella, Angelo Zigliani, Davide Farina & Roberto Maroldi. (2021) Lombardy, Northern Italy: COVID-19 second wave less severe and deadly than the first? A preliminary investigation. Infectious Diseases 53:5, pages 370-375.
Read now

Articles from other publishers (3)

Somayeh Sadeghi, Maryam Nasirian, Elaheh Keivany, Peiman Nasri & Maryam Sadat Mirenayat. (2021) The demographic, clinical, and medical manifestations of pulmonary thromboembolism development in COVID-19. BLOOD RESEARCH 56:4, pages 293-300.
Crossref
Calin Pop & Ionuț Ferenț. (2021) High D-dimer values and post-discharge acute pulmonary embolism in young patients with COVID-19: A case series. Sanamed 16:1, pages 85-90.
Crossref
Hareton Teixeira Vechi, Lucas Rodrigues Maia & Manoella do Monte Alves. (2020) Late acute pulmonary embolism after mild Coronavirus Disease 2019 (COVID-19): a case series. Revista do Instituto de Medicina Tropical de São Paulo 62.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.